INOVIQ Ltd

INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based solutions for the earlier detection, diagnosis, prognosis and monitoring of cancer and other diseases to improve patient outcomes and save lives. INOVIQ’s multiomics approach, using our unique biomarker isolation and detection technologies, has enabled us to develop liquid biopsy tests for earlier and more accurate detection of cancer and other diseases. INOVIQ as it offers us the opportunity to develop SubB2M-based SPR tests for multi-cancer detection and monitoring via Nicoya’s Alto instrument that has the potential to be used in pathology laboratories worldwide.